Patents by Inventor Goeril Karlsson

Goeril Karlsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Paediatric Compositions For Treating Multiple Sclerosis
    Publication number: 20210023027
    Abstract: The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutical/acceptable salt thereof, and to the use thereof far treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.
    Type: Application
    Filed: October 7, 2020
    Publication date: January 28, 2021
    Inventors: John M. Kovarik, Robert Schmouder, Marie-Claude Bastien, Olivier David, Goeril Karlsson
  • Paediatric Compositions For Treating Multiple Sclerosis
    Publication number: 20200197334
    Abstract: The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.
    Type: Application
    Filed: March 4, 2020
    Publication date: June 25, 2020
    Inventors: John M. Kovarik, Robert Schmouder, Marie-Claude Bastien, Olivier David, Goeril Karlsson
  • Paediatric Compositions For Treating Multiple Sclerosis
    Publication number: 20190358178
    Abstract: The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.
    Type: Application
    Filed: August 7, 2019
    Publication date: November 28, 2019
    Inventors: John M. Kovarik, Robert Schmouder, Marie-Claude Bastien, Olivier David, Goeril Karlsson
  • Paediatric Compositions for Treating Multiple Sclerosis
    Publication number: 20190117593
    Abstract: The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a pediatric patient or a patient suffering from a specific condition.
    Type: Application
    Filed: October 31, 2018
    Publication date: April 25, 2019
    Inventors: John Kovarik, Robert Schmouder, Marie-Claude Bastien, Olivier David, Goeril Karlsson
  • Paediatric Compositions For Treating Multiple Sclerosis
    Publication number: 20180177747
    Abstract: The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20- alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.
    Type: Application
    Filed: February 22, 2018
    Publication date: June 28, 2018
    Inventors: John M. Kovarik, Robert Schmouder, Marie-Claude Bastien, Olivier David, Goeril Karlsson
  • Paediatric Compositions For Treating Multiple Sclerosis
    Publication number: 20170333368
    Abstract: The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-C20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.
    Type: Application
    Filed: August 8, 2017
    Publication date: November 23, 2017
    Inventors: Marie-Claude Bastien, Robert Schmouder, Marie-Claude Bastien, Olivier David, Goeril Karlsson
  • Paediatric Compositions For Treating Multiple Sclerosis
    Publication number: 20170128389
    Abstract: The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.
    Type: Application
    Filed: January 20, 2017
    Publication date: May 11, 2017
    Inventors: John M. Kovarik, Robert Schmouder, Marie-Claude Bastien, Olivier David, Goeril Karlsson
  • Paediatric Compositions For Treating Multiple Sclerosis
    Publication number: 20160206574
    Abstract: The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.
    Type: Application
    Filed: March 31, 2016
    Publication date: July 21, 2016
    Applicant: Novartis AG
    Inventors: John M. Kovarik, Robert Schmouder, Marie-Claude Bastien, Olivier David, Goeril Karlsson
  • Paediatric Compositions For Treating Multiple Sclerosis
    Publication number: 20160022611
    Abstract: The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.
    Type: Application
    Filed: October 2, 2015
    Publication date: January 28, 2016
    Inventors: John M. Kovarik, Robert Schmouder, Marie-Claude Bastien, Olivier David, Goeril Karlsson
  • Paediatric Compositions For Treating Multiple Sclerosis
    Publication number: 20130230489
    Abstract: The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20-alkyl-phenypethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.
    Type: Application
    Filed: March 18, 2013
    Publication date: September 5, 2013
    Inventors: John M. Kovarik, Robert Schmouder, Marie-Claude Bastien, David Olivier, Goeril Karlsson
  • Paediatric Compositions For Treating Multiple Sclerosis
    Publication number: 20110152380
    Abstract: The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a pediatric patient or a patient suffering from a specific condition.
    Type: Application
    Filed: June 19, 2009
    Publication date: June 23, 2011
    Inventors: John M. Kovarik, Robert Schmouder, Marie-Claude Bastien, Olivier David, Goeril Karlsson, Thomas Bouillon